Cost-effectiveness of newer antiplatelet drugs

Arch Intern Med. 2003 Nov 10;163(20):2533-4; author reply 2534. doi: 10.1001/archinte.163.20.2533-b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin / economics*
  • Clopidogrel
  • Cost-Benefit Analysis
  • Drug Costs*
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / economics*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / economics*

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin